Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Syndrome by Seini Moimoi | Jun 3, 2021 | Portfolio News
Theseus Pharmaceuticals Appoints Brad Dahms as Chief Financial Officer by Seini Moimoi | Jun 2, 2021 | Portfolio News
Axonics® Receives FDA Approval Further Expanding MRI Labeling by Seini Moimoi | May 20, 2021 | Portfolio News
Axonics® Announces CE Mark Approval for Implantable Sacral Neurostimulator that Significantly Extends Recharge Interval by Seini Moimoi | May 18, 2021 | Portfolio News
Vera Therapeutics Announces Pricing of Initial Public Offering by Seini Moimoi | May 13, 2021 | Portfolio News
